Traxion Sab De Cv Ord Shs GRPOF

RE:Facts Matter! NR = Dilution, great timing, busy week huh.

[stocktickler87]

LeafRider wrote: I guess someone comes in now and tells me that everything is fine, the fact is this things is going to drift all right and what matters is honesty.

Gee what's the hurry, I guess I know why we were held back all this time. I wonder if we look at the test results we had available at the phase1 and 2 trials and see if they were dealing with these same mycotoxins? I sure hope not.

This will be great for the SP. 

Tetra Bio-Pharma Announces Stock Option Grants

08 February, 2019

 

ORLEANS, Ontario, Feb. 08, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. ("Tetra" or the "Corporation") (TSX VENTURE: TBP) (OTB: TBPMF), announces today that it has granted, pursuant to the Company's stock option plan (the "Plan"), 375,000 options to officers of the Company. Each option entitles its holder to purchase one common share of the Company.

300,000 options will become vested in four 6-month tranches of 75,000 options, are exercisable at a price of $0.69 and will expire on December 24, 2022. 75,000 options vest immediately, are exercisable for a period of four years at a price of $0.69 and will expire on February 8, 2023. All of the options are subject to the terms of the Plan and the requirements of the TSX Venture Exchange. 

As approved at the annual meeting of shareholders of the Company held on June 19, 2018, the Plan allows the Company to issue the equivalent of up to 10% of the number of issued and outstanding common shares from time to time. There are currently 166,831,731 issued and outstanding common shares.

A bout Tetra Bio-Pharma Inc. 
Tetra Bio-Pharma (TSX-V: TBP) (OTCQB: TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a Health Canada approved, and FDA reviewed, clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. The Company has several subsidiaries engaged in the development of an advanced and growing pipeline of Bio Pharmaceuticals, Natural Health and Veterinary Products containing cannabis and other medicinal plant-based elements. With patients at the core of what we do, Tetra Bio-Pharma is focused on providing rigorous scientific validation and safety data required for inclusion into the existing bio pharma industry by regulators, physicians and insurance companies.

For more information visit: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

If everyone here had weak hands like you than yes, this would be negative news. But that isn't the case. This wasn't a suprise as indicated in the release. Not saying it's awesome...but time marches forward.